Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelParallel CC TiUltra RP 5.0x13mm: medical device reports filed with FDA

832 reports name it, 2021–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

832
device reports naming the brand
0% of all MAUDE reports · about 151 a year
150
reports, 12 months to August 2026
152 in the 12 months before
1.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 832 reports that name the brand "NobelParallel CC TiUltra RP 5.0x13mm" (endosseous dental implant), received between January 2021 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

150 reports arrived in the 12 months to August 2026, close to the 152 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.9%) and malfunction (1.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.3%), loss of osseointegration (12.5%) and osseointegration problem (7.2%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02754Sep 2021: 12Oct 2021: 14Nov 2021: 4Dec 2021: 22022Jan 2022: 10Feb 2022: 8Mar 2022: 12Apr 2022: 12May 2022: 10Jun 2022: 24Jul 2022: 18Aug 2022: 10Sep 2022: 18Oct 2022: 18Nov 2022: 18Dec 2022: 222023Jan 2023: 6Feb 2023: 14Mar 2023: 26Apr 2023: 14May 2023: 18Jun 2023: 10Jul 2023: 16Aug 2023: 22Sep 2023: 14Oct 2023: 10Nov 2023: 6Dec 2023: 22024Jan 2024: 22Feb 2024: 8Mar 2024: 12Apr 2024: 8May 2024: 14Jun 2024: 4Jul 2024: 26Aug 2024: 12Sep 2024: 10Oct 2024: 6Nov 2024: 14Dec 2024: 162025Jan 2025: 14Feb 2025: 8Mar 2025: 14Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 54Aug 2025: 16Sep 2025: 18Oct 2025: 14Nov 2025: 16Dec 2025: 142026Jan 2026: 8Feb 2026: 12Mar 2026: 22Apr 2026: 10May 2026: 10Jun 2026: 8Jul 2026: 10Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0901802021: 8620212022: 18020222023: 15820232024: 15220242025: 16820252026: 882026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.9%823
Malfunction1.1%9
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%416
Voluntary report0%0
User facility report0%0
Distributor report50%416
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate61073.3%62.8%
Loss of osseointegration10412.5%22.4%
Osseointegration problem607.2%7.7%
Patient device interaction problem202.4%0.3%
Device markings/labelling problema problem with the device markings or label81%0%
Malposition of device60.7%0.1%
Contamination /decontamination problem20.2%0%
Fracturea broken bone20.2%1.6%
Insufficient device problem information20.2%0.2%
Mechanical problema mechanical problem20.2%0.1%
Migrationthe device moved from where it was placed20.2%0.1%
Separation failure20.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant58470.2%
Painpain, site not specified8610.3%
Numbnessnumbness283.4%
Implant pain141.7%
Appropriate clinical signs, symptoms and conditions term/code not available81%
Inflammationinflammation81%
Fistula40.5%
Sinus perforation40.5%
Abscessa collection of pus20.2%
Bone fracture(s)20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelParallel CC TiUltra RP 5.0x13mmProduct code DZEAll MAUDE reports
Reports8323,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.9%99.2%36.2%
Classified as malfunction1.1%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelParallel CC TiUltra RP 5.0x13mm reports

How many FDA reports name NobelParallel CC TiUltra RP 5.0x13mm?

832 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 150 in the latest 12 months.

What kinds of events are reported?

injury (98.9%) and malfunction (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.3%), loss of osseointegration (12.5%), osseointegration problem (7.2%), patient device interaction problem (2.4%) and device markings/labelling problem (1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelParallel CC TiUltra RP 5.0x13mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.